IB Net Payout Yields Model

DocuSign: Sign Up Here

  • DocuSign has fallen to near all-time lows as the growth rate slows following a few strong years with covid.
  • The e-signature company continues to provide tepid guidance while constantly smashing estimates with the next test coming up for FQ1 on June 8.
  • The stock is cheap at 21x FY25 EPS estimates that are likely conservative.
  • This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » 
As a covid beneficiary, DocuSign (NASDAQ:DOCU) growth is regularly diminished, yet the e-signature company continues to grow beyond the original surge. The company definitely faces a tough macro environment, but DocuSign continues to outperform while providing conservative guidance. My 

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 


Popular posts from this blog

Aurora Cannabis: Deal Or No Deal

C3.ai: Out Of Steam (Rating Downgrade)

Archer Aviation: Promising Developments